WallStreetZenWallStreetZen

NASDAQ: ATRC
Atricure Inc Stock

$23.39-0.06 (-0.26%)
Updated Apr 18, 2024
ATRC Price
$23.39
Fair Value Price
$24.84
Market Cap
$1.11B
52 Week Low
$22.42
52 Week High
$59.61
P/E
-35.44x
P/B
2.39x
P/S
4.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$399.25M
Earnings
-$30.44M
Gross Margin
75.2%
Operating Margin
-5.74%
Profit Margin
-7.6%
Debt to Equity
0.32
Operating Cash Flow
$4M
Beta
1.07
Next Earnings
Apr 30, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ATRC Overview

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATRC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATRC ($23.39) is undervalued by 5.85% relative to our estimate of its Fair Value price of $24.84 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ATRC ($23.39) is not significantly undervalued (5.85%) relative to our estimate of its Fair Value price of $24.84 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ATRC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ATRC due diligence checks available for Premium users.

Be the first to know about important ATRC news, forecast changes, insider trades & much more!

ATRC News

Valuation

ATRC fair value

Fair Value of ATRC stock based on Discounted Cash Flow (DCF)
Price
$23.39
Fair Value
$24.84
Undervalued by
5.85%
ATRC ($23.39) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATRC ($23.39) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATRC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATRC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-35.44x
Industry
49.62x
Market
41.33x

ATRC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.39x
Industry
3.48x
ATRC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATRC's financial health

Profit margin

Revenue
$106.5M
Net Income
-$9.8M
Profit Margin
-9.2%
ATRC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ATRC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$613.9M
Liabilities
$147.8M
Debt to equity
0.32
ATRC's short-term assets ($266.25M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATRC's short-term assets ($266.25M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATRC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ATRC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$4.0M
Investing
-$2.8M
Financing
$2.4M
ATRC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATRC vs Medical Stocks

TickerMarket Cap1d %P/EP/B
ATRC$1.11B-0.26%-35.44x2.39x
LMAT$1.40B-0.67%46.04x4.70x
WRBY$1.40B-1.74%-22.00x4.65x
BLFS$718.46M+4.76%-10.43x2.13x
ATRI$678.77M-3.28%35.00x2.79x

Atricure Stock FAQ

What is Atricure's quote symbol?

(NASDAQ: ATRC) Atricure trades on the NASDAQ under the ticker symbol ATRC. Atricure stock quotes can also be displayed as NASDAQ: ATRC.

If you're new to stock investing, here's how to buy Atricure stock.

What is the 52 week high and low for Atricure (NASDAQ: ATRC)?

(NASDAQ: ATRC) Atricure's 52-week high was $59.61, and its 52-week low was $22.42. It is currently -60.76% from its 52-week high and 4.35% from its 52-week low.

How much is Atricure stock worth today?

(NASDAQ: ATRC) Atricure currently has 47,587,966 outstanding shares. With Atricure stock trading at $23.39 per share, the total value of Atricure stock (market capitalization) is $1.11B.

Atricure stock was originally listed at a price of $14.08 in Aug 5, 2005. If you had invested in Atricure stock at $14.08, your return over the last 18 years would have been 66.12%, for an annualized return of 2.86% (not including any dividends or dividend reinvestments).

How much is Atricure's stock price per share?

(NASDAQ: ATRC) Atricure stock price per share is $23.39 today (as of Apr 18, 2024).

What is Atricure's Market Cap?

(NASDAQ: ATRC) Atricure's market cap is $1.11B, as of Apr 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Atricure's market cap is calculated by multiplying ATRC's current stock price of $23.39 by ATRC's total outstanding shares of 47,587,966.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.